TIDMNPH TIDMLLOY
RNS Number : 0136C
Neuropharm Group PLC
05 November 2009
?
+-----------------------------------+------------------------------------------+
| For immediate release | 5 November 2009 |
+-----------------------------------+------------------------------------------+
Neuropharm Group plc
("Neuropharm" or the "Company")
TR-1: Notification of Major Interests in Shares
+------------------------------------------------+------------------------------+
| 1. Identity of the issuer or the underlying | Neuropharm Group plc |
| issuer of existing shares to which voting | |
| rights are attached: | |
+------------------------------------------------+------------------------------+
| 2. Reason for the notification | |
+------------------------------------------------+------------------------------+
| An acquisition or disposal of voting rights | Yes |
+------------------------------------------------+------------------------------+
| Other (please specify): | Disclosure of holdings |
| | follows the sale of Insight |
| | Investment Management |
| | Limited on 2 November 2009. |
| | This notification supersedes |
| | any notifications previously |
| | issued by Lloyds Banking |
| | Group plc. |
+------------------------------------------------+------------------------------+
| 3. Full name of person(s) subject to the | Lloyds Banking Group plc |
| notification obligation: | |
+------------------------------------------------+------------------------------+
| 4. Full name of shareholder(s) (if different | See Section 9. |
| from 3.): | |
+------------------------------------------------+------------------------------+
| 5. Date of the transaction and date on which | 02 November 2009 |
| the threshold is crossed or reached: | |
+------------------------------------------------+------------------------------+
| 6. Date on which issuer notified: | 04 November 2009 |
+------------------------------------------------+------------------------------+
| 7. Threshold(s) that is/are crossed or | N/A - direct/indirect |
| reached: | holdings remain above 9% |
+------------------------------------------------+------------------------------+
+---------------+-------------+------------+------------+--------------------+----+------------+---------------+-----+----+
| 8. Notified details: | |
+----------------------------------------------------------------------------+---------------------------------------+
| A: Voting rights attached to shares |
+-------------------------------------------------------------------------------------------------------------------------+
| Class/type | Situation previous to | Resulting situation after the triggering |
| of shares | the Triggering | transaction |
| if possible | transaction | |
| using the | | |
| ISIN CODE | | |
+ +--------------------------+------------------------------------------------------------------------------+
| | Number of | Number of | Number of | Number of voting | % of voting rights |
| | Shares | Voting | shares | rights | |
| | | Rights | Direct | | |
+ + + + +--------------------------------------+--------------------------+
| | | | | Direct | Indirect | Direct |Indirect |
+---------------+-------------+------------+------------+-------------------------+------------+---------------+----------+
| Ord 10p | 3,036,615 | 3,036,615 | 1,328,394 | 1,328,394 | 1,708,222 | 4.212% | 5.417% |
| Shares | | | | | | | |
+---------------+ + + + + + + +
| GB00B1NPJJ01 | | | | | | | |
+---------------+-------------+------------+------------+--------------------+----+------------+---------------+-----+----+
+----------------+------------+-------------------+--------------------+------------+
| B: Financial Instruments |
+-----------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+-----------------------------------------------------------------------------------+
| Type of | Expiration | Exercise/ | Number of voting | % of |
| financial | date | Conversion | rights that may be | voting |
| instrument | | Period/ Date | acquired if the | rights |
| | | | instrument is | |
| | | | exercised/ | |
| | | | converted | |
+----------------+------------+-------------------+--------------------+------------+
| | | | | |
+----------------+------------+-------------------+--------------------+------------+
+-----------------+----------+--------------+---------------------+----------------+
| C: Financial Instruments with similar economic effect to Qualifying Financial |
| Instruments |
+----------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
+----------------------------------------------------------------------------------+
| Type of | Exercise | Expiration | Number of voting | % of voting |
| financial | price | date | rights instrument | rights |
| instrument | | | refers to | |
| | | | | |
+-----------------+----------+--------------+---------------------+----------------+
| | | | | |
+-----------------+----------+--------------+---------------------+----------------+
+--------------------------------------+----------------------------------------+
| Total (A+B+C) |
+-------------------------------------------------------------------------------+
| Number of voting rights | % of voting rights |
+--------------------------------------+----------------------------------------+
| 3,036,616 | 9.629% |
+--------------------------------------+----------------------------------------+
+-----------------------------------------------------------------------------+
| 9. Chain of controlled undertakings through which the voting rights and/or |
| the financial instruments are effectively held, if applicable: |
+-----------------------------------------------------------------------------+
| 3,036,607 shares (9.629%) are under the control of Scottish Widows |
| Investment Partnership Ltd, a wholly owned subsidiary of Scottish Widows |
| Group Ltd, a wholly owned subsidiary of Lloyds TSB Bank plc, a wholly owned |
| subsidiary of Lloyds Banking Group plc (Direct/Indirect Interests). |
| Within these holdings 22,658 shares (0.072%) are managed on behalf of |
| Clerical Medical Managed Funds Limited a wholly owned subsidiary of |
| Clerical Medical Investment Group Limited, and a further 1,305,727 shares |
| (4.140%) are managed on behalf of Clerical Medical Investment Group |
| Limited, a wholly owned subsidiary of HBOS Financial Services Limited, a |
| wholly owned subsidiary of HBOS Insurance & Investment Group Limited a |
| wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds |
| Banking Group plc, These holdings are therefore disclosed as an overall |
| Direct Interest. |
+-----------------------------------------------------------------------------+
+-------------------------------------------------+----------------------------+
| Proxy Voting: |
+------------------------------------------------------------------------------+
| 10. Name of the proxy holder: | N/A |
+-------------------------------------------------+----------------------------+
| 11. Number of voting rights proxy holder will | N/A |
| cease to hold: | |
+-------------------------------------------------+----------------------------+
| 12. Date on which proxy holder will cease to | N/A |
| hold voting rights: | |
+-------------------------------------------------+----------------------------+
+---------------------------------+--------------------------------------------+
| 13. Additional information: | Notification using the Total Voting Rights |
| | figure of 31,536,697 |
+---------------------------------+--------------------------------------------+
| 14. Contact name: | Matthew Wilson |
+---------------------------------+--------------------------------------------+
| 15. Contact telephone number: | 0113 235 7729 |
+---------------------------------+--------------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUVSWRKBRARRA
|